Correlation Between Avanos Medical and Onxeo SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avanos Medical and Onxeo SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avanos Medical and Onxeo SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avanos Medical and Onxeo SA, you can compare the effects of market volatilities on Avanos Medical and Onxeo SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avanos Medical with a short position of Onxeo SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avanos Medical and Onxeo SA.

Diversification Opportunities for Avanos Medical and Onxeo SA

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Avanos and Onxeo is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Avanos Medical and Onxeo SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Onxeo SA and Avanos Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avanos Medical are associated (or correlated) with Onxeo SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Onxeo SA has no effect on the direction of Avanos Medical i.e., Avanos Medical and Onxeo SA go up and down completely randomly.

Pair Corralation between Avanos Medical and Onxeo SA

Assuming the 90 days trading horizon Avanos Medical is expected to generate 0.13 times more return on investment than Onxeo SA. However, Avanos Medical is 7.65 times less risky than Onxeo SA. It trades about 0.03 of its potential returns per unit of risk. Onxeo SA is currently generating about -0.01 per unit of risk. If you would invest  1,510  in Avanos Medical on October 23, 2024 and sell it today you would earn a total of  10.00  from holding Avanos Medical or generate 0.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy94.12%
ValuesDaily Returns

Avanos Medical  vs.  Onxeo SA

 Performance 
       Timeline  
Avanos Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avanos Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Onxeo SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Onxeo SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Onxeo SA is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Avanos Medical and Onxeo SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avanos Medical and Onxeo SA

The main advantage of trading using opposite Avanos Medical and Onxeo SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avanos Medical position performs unexpectedly, Onxeo SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onxeo SA will offset losses from the drop in Onxeo SA's long position.
The idea behind Avanos Medical and Onxeo SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world